IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 14 holdings | $2.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Caredx Inc(CDNA)COM14167L103$2.0M64,94498.2%
Thermo Fisher Scientific Inc(TMO)COM883556102$5.2K18,9900.2%
Zoetis Inc(ZTS)CL A98978V103$5.1K50,4130.2%
Bristol Myers Squibb Co(BMY)COM110122108$4.1K85,0000.2%
Heron Therapeutics Inc(HRTX)COM427746102$3.3K135,9460.2%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$3.3K17,8630.2%
Unitedhealth Group Inc(UNH)COM91324P102$3.0K12,0000.1%
Stryker Corp(SYK)COM863667101$2.9K14,6080.1%
Iqvia Hldgs Inc(IQV)COM46266C105$2.9K20,0000.1%
Gilead Sciences Inc(GILD)COM375558103$2.7K40,9460.1%
Horizon Pharma PLCSHSG4617B105$1.7K66,0000.1%
Illumina Inc(ILMN)COM452327109$1.7K5,3200.1%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$9141,6020.0%
Nevro Corp(NVROEUR)COM64157F103$3135,0000.0%